|
1
|
Pingping B, Yuhong Z, Weiqi L, Chunxiao W,
Chunfang W, Yuanjue S, Chenping Z, Jianru X, Jiade L, Lin K, et al:
Incidence and mortality of sarcomas in Shanghai, China, during
2002–2014. Front Oncol. 9:6622019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Harrison DJ, Geller DS, Gill JD, Lewis VO
and Gorlick R: Current and future therapeutic approaches for
osteosarcoma. Expert Rev Anticancer Ther. 18:39–50. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin YH, Jewell BE, Gingold J, Lu L, Zhao
R, Wang LL and Lee DF: Osteosarcoma: Molecular pathogenesis and
iPSC modeling. Trends Mol Med. 23:737–755. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hu Q, Li S, Chen C, Zhu M, Chen Y and Zhao
Z: 17β-estradiol treatment drives Sp1 to upregulate MALAT-1
expression and epigenetically affects physiological processes in
U2OS cells. Mol Med Rep. 15:1335–1342. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li M, Zeng M, Zhang Z, Zhang J, Zhang B,
Zhao X, Zheng X and Feng W: Uridine derivatives from the seeds of
Lepidium apetalum Willd. And their estrogenic effects.
Phytochemistry. 155:45–52. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
van Duursen MB, Smeets EE, Rijk JC,
Nijmeijer SM and van den Berg M: Phytoestrogens in menopausal
supplements induce ER-dependent cell proliferation and overcome
breast cancer treatment in an in vitro breast cancer model. Toxicol
Appl Pharmacol. 269:132–140. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin AH, Li RW, Ho EY, Leung GP, Leung SW,
Vanhoutte PM and Man RY: Differential ligand binding affinities of
human estrogen receptor-α isoforms. PLoS One. 8:e631992013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao X, Li X, Ren Q, Tian J and Chen J:
Calycosin induces apoptosis in colorectal cancer cells, through
modulating the ERβ/MiR-95 and IGF-1R, PI3K/Akt signaling pathways.
Gene. 591:123–128. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen J, Hou R, Zhang X, Ye Y, Wang Y and
Tian J: Calycosin suppresses breast cancer cell growth via
ERβ-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways.
PLoS One. 9:e912452014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun H, Yin M, Qian W and Yin H: Calycosin,
a Phytoestrogen isoflavone, induces apoptosis of estrogen
receptor-positive MG-63 osteosarcoma cells via the
phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of
rapamycin (mTOR) pathway. Med Sci Monit. 24:6178–6186. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Renoir JM: Estradiol receptors in breast
cancer cells: Associated co-factors as targets for new therapeutic
approaches. Steroids. 77:1249–1261. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Wei F, Zhang J Hao L, Jiang J,
Dang L, Mei D, Fan S, Yu Y and Jiang L: Bisphenol A and estrogen
induce proliferation of human thyroid tumor cells via an
estrogen-receptor-dependent pathway. Arch Biochem Biophys.
633:29–39. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Treeck O, Diepolder E, Skrzypczak M,
Schüler-Toprak S and Ortmann O: Knockdown of estrogen receptor β
increases proliferation and affects the transcriptome of
endometrial adenocarcinoma cells. BMC Cancer. 19:7452019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li H, Tu Z, An L, Qian Z, Achilefu S and
Gu Y: Inhibitory effects of ERβ on proliferation, invasion, and
tumor formation of MCF-7 breast cancer cells-prognostication for
the use of ERβ-selective therapy. Pharm Biol. 50:839–849. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu CP, Ho JY, Huang YT, Cha TL, Sun GH, Yu
DS, Chang FW, Chen SP and Hsu RJ: Estrogen inhibits renal cell
carcinoma cell progression through estrogen receptor-β activation.
PLoS One. 8:e566672013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang M, Liu B, Jin L, Tao H and Yang Z:
Estrogen receptor β exhibited anti-tumor effects on osteosarcoma
cells by regulating integrin, IAP, NF-kB/BCL-2 and PI3K/Akt signal
pathway. J Bone Oncol. 9:15–20. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang J, Yu XH, Yan YG, Wang C and Wang
WJ: PI3K/Akt signaling in osteosarcoma. Clin Chim Acta.
444:182–192. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu Y, Li N, Xiang R and Sun P: Emerging
roles of the p38 MAPK and PI3K/AKT/mTOR pathways in
oncogene-induced senescence. Trends Biochem Sci. 39:268–76. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang J, Zhang C, Chen K, Tang H, Tang J,
Song C and Xie X: ERβ1 inversely correlates with PTEN/PI3K/AKT
pathway and predicts a favorable prognosis in triple-negative
breast cancer. Breast Cancer Res Treat. 152:255–269. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gupta S, Kass GE, Szegezdi E and Joseph B:
The mitochondrial death pathway: A promising therapeutic target in
diseases. J Cell Mol Med. 13:1004–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Botter SM, Neri D and Fuchs B: Recent
advances in osteosarcoma. Curr Opin Pharmacol. 16:15–23. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hwang KA, Park MA, Kang NH, Yi BR, Hyun
SH, Jeung EB and Choi KC: Anticancer effect of genistein on BG-1
ovarian cancer growth induced by 17 β-estradiol or bisphenol A via
the suppression of the crosstalk between estrogen receptor α and
insulin-like growth factor-1 receptor signaling pathways. Toxicol
Appl Pharmacol. 272:637–646. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thelen P, Wuttke W and Seidlová-Wuttke D:
Phytoestrogens selective for the estrogen receptor beta exert
anti-androgenic effects in castration resistant prostate cancer. J
Steroid Biochem Mol Biol. 139:290–293. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qiu R, Li X, Qin K, Chen X, Wang R, Dai Y,
Deng L and Ye Y: Antimetastatic effects of calycosin on
osteosarcoma and the underlying mechanism. Biofactors. 45:975–982.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen J, Zhao X, Ye Y, Wang Y and Tian J:
Estrogen receptor beta-mediated proliferative inhibition and
apoptosis in human breast cancer by calycosin and formononetin.
Cell Physiol Bioch. 32:1790–1797. 2013. View Article : Google Scholar
|
|
26
|
Zhou R, Chen H, Chen J, Chen X, Wen Y and
Xu L: Extract from Astragalus membranaceus inhibit breast
cancer cells proliferation via PI3K/AKT/mTOR signaling pathway. BMC
Complement Altern Med. 18:832018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gorska M, Wyszkowska RM, Kuban-Jankowska A
and Wozniak M: Impact of apparent antagonism of estrogen receptor β
by fulvestrant on anticancer activity of 2-methoxyestradiol.
Anticancer Res. 36:2217–2226. 2016.PubMed/NCBI
|
|
28
|
Kanaizumi H, Higashi C, Tanaka Y, Hamada
M, Shinzaki W, Azumi T, Hashimoto Y, Inui H, Houjou T and Komoike
Y: PI3K/Akt/mTOR signalling pathway activation in patients with
ER-positive, metachronous, contralateral breast cancer treated with
hormone therapy. Oncol Lett. 17:1962–1968. 2019.PubMed/NCBI
|
|
29
|
Hassan M, Watari H, AbuAlmaaty A, Ohba Y
and Sakuragi N: Apoptosis and molecular targeting therapy in
cancer. Biomed Res Int. 2014:1508452014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qiu R, Ma G, Zheng C, Qiu X, Li X, Li X,
Mo J, Li Z, Liu Y, Mo L, et al: Antineoplastic effect of calycosin
on osteosarcoma through inducing apoptosis showing in vitro and in
vivo investigations. Exp Mol Pathol. 97:17–22. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kopeina GS, Prokhorova EA, Lavrik IN and
Zhivotovsky B: Alterations in the nucleocytoplasmic transport in
apoptosis: Caspases lead the way. Cell Prolif. 51:e124672018.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Akanda MR, Kim MJ, Kim IS, Ahn D, Tae HJ,
Rahman MM, Park YG, Seol JW, Nam HH, Choo BK and Park BY:
Neuroprotective effects of sigesbeckia pubescens extract on
glutamate-induced oxidative stress in HT22 cells via downregulation
of MAPK/caspase-3 pathways. Cell Mol Neurobiol. 38:497–505. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rogalska A, Bukowska B and Marczak A:
Metformin and epothilone A treatment up regulate pro-apoptotic
PARP-1, Casp-3 and H2AX genes and decrease of AKT kinase level to
control cell death of human hepatocellular carcinoma and ovary
adenocarcinoma cells. Toxicol In Vitro. 47:48–62. 2018. View Article : Google Scholar : PubMed/NCBI
|
